Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen

To assess the changing estradiol (E2) and follicle-stimulating hormone (FSH) level in oophorectomized women using vaginal estrogen. Serum estradiol and FSH were evaluated in 32 oophorectomized women using a daily dose of 2 g base of 1.25 mg vaginal conjugated equine estrogen (CEE) cream. The blood s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the Medical Association of Thailand 1997-10, Vol.80 (10), p.626-630
Hauptverfasser: Taechakraichana, N, Intraragsakul, A, Panyakhamlerd, K, Numchaisrika, P, Limpaphayom, K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 630
container_issue 10
container_start_page 626
container_title Journal of the Medical Association of Thailand
container_volume 80
creator Taechakraichana, N
Intraragsakul, A
Panyakhamlerd, K
Numchaisrika, P
Limpaphayom, K
description To assess the changing estradiol (E2) and follicle-stimulating hormone (FSH) level in oophorectomized women using vaginal estrogen. Serum estradiol and FSH were evaluated in 32 oophorectomized women using a daily dose of 2 g base of 1.25 mg vaginal conjugated equine estrogen (CEE) cream. The blood sample for hormone assay was collected 8-10 hours from the time of vaginal application. E2 and FSH levels were measured in the serum sample before and after commencing the study at 4, 8 and 12 weeks using the time-resolved fluoroimmunoassay method. Serum estradiol significantly increased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of E2 value at 0, 4, 8, 12 weeks: 9.97 +/- 12.13, 249.83 +/- 170.46, 299.38 +/- 190.65, 322.82 +/- 218.31 pmol/L, respectively, P < 0.05) On the other hand, serum FSH significantly decreased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of FSH value at 0, 4, 8, 12 weeks: 77.64 +/- 27.24, 40.33 +/- 21.64, 38.84 +/- 22.33, 30.90 +/- 24.32 IU/L, respectively, P < 0.05) In conclusion, a daily dose of 2 g vaginal CEE cream raised the serum estradiol level close to the normal level in the follicular phase of the normal menstrual cycle. However, even though FSH significantly decreased it did not reach the premenopausal level.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78721020</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78721020</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-e4b9bf829fc20dac2e24172bb9691e06ed0a141b395d7a73c4c9449cd0a8b0cc3</originalsourceid><addsrcrecordid>eNo1kE1LxDAYhHNQ3HX1L0hO3gpJmn7kKMv6AQte9FzeJG_XSD5q067or7fieppheJiBOSNrxkVVCMHaFbnM-Z0xWam6vCArztTia7kmsMvTCNYlTyFa2ifvnfFY5MmF2cPk4oG-pTGkiNTjEX2mLtKUhiVEM6XgvtHSzxQw0jn_0kc4uAie4lKcDhivyHkPPuP1STfk9X73sn0s9s8PT9u7fTFwIaYCpVa6b4XqjWAWjEAheSO0VrXiyGq0DLjkulSVbaApjTRKSmWWuNXMmHJDbv96hzF9zMt6F1w26D1ETHPumrYRnAm2gDcncNYBbTeMLsD41f2fUv4AOXhfjw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78721020</pqid></control><display><type>article</type><title>Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Taechakraichana, N ; Intraragsakul, A ; Panyakhamlerd, K ; Numchaisrika, P ; Limpaphayom, K</creator><creatorcontrib>Taechakraichana, N ; Intraragsakul, A ; Panyakhamlerd, K ; Numchaisrika, P ; Limpaphayom, K</creatorcontrib><description>To assess the changing estradiol (E2) and follicle-stimulating hormone (FSH) level in oophorectomized women using vaginal estrogen. Serum estradiol and FSH were evaluated in 32 oophorectomized women using a daily dose of 2 g base of 1.25 mg vaginal conjugated equine estrogen (CEE) cream. The blood sample for hormone assay was collected 8-10 hours from the time of vaginal application. E2 and FSH levels were measured in the serum sample before and after commencing the study at 4, 8 and 12 weeks using the time-resolved fluoroimmunoassay method. Serum estradiol significantly increased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of E2 value at 0, 4, 8, 12 weeks: 9.97 +/- 12.13, 249.83 +/- 170.46, 299.38 +/- 190.65, 322.82 +/- 218.31 pmol/L, respectively, P &lt; 0.05) On the other hand, serum FSH significantly decreased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of FSH value at 0, 4, 8, 12 weeks: 77.64 +/- 27.24, 40.33 +/- 21.64, 38.84 +/- 22.33, 30.90 +/- 24.32 IU/L, respectively, P &lt; 0.05) In conclusion, a daily dose of 2 g vaginal CEE cream raised the serum estradiol level close to the normal level in the follicular phase of the normal menstrual cycle. However, even though FSH significantly decreased it did not reach the premenopausal level.</description><identifier>ISSN: 0125-2208</identifier><identifier>PMID: 10904564</identifier><language>eng</language><publisher>Thailand</publisher><subject>Administration, Topical ; Adult ; Estradiol - blood ; Estrogens - administration &amp; dosage ; Female ; Follicle Stimulating Hormone - blood ; Humans ; Middle Aged ; Osteoporosis, Postmenopausal - prevention &amp; control ; Ovariectomy ; Thailand ; Treatment Outcome ; Vagina</subject><ispartof>Journal of the Medical Association of Thailand, 1997-10, Vol.80 (10), p.626-630</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10904564$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Taechakraichana, N</creatorcontrib><creatorcontrib>Intraragsakul, A</creatorcontrib><creatorcontrib>Panyakhamlerd, K</creatorcontrib><creatorcontrib>Numchaisrika, P</creatorcontrib><creatorcontrib>Limpaphayom, K</creatorcontrib><title>Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen</title><title>Journal of the Medical Association of Thailand</title><addtitle>J Med Assoc Thai</addtitle><description>To assess the changing estradiol (E2) and follicle-stimulating hormone (FSH) level in oophorectomized women using vaginal estrogen. Serum estradiol and FSH were evaluated in 32 oophorectomized women using a daily dose of 2 g base of 1.25 mg vaginal conjugated equine estrogen (CEE) cream. The blood sample for hormone assay was collected 8-10 hours from the time of vaginal application. E2 and FSH levels were measured in the serum sample before and after commencing the study at 4, 8 and 12 weeks using the time-resolved fluoroimmunoassay method. Serum estradiol significantly increased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of E2 value at 0, 4, 8, 12 weeks: 9.97 +/- 12.13, 249.83 +/- 170.46, 299.38 +/- 190.65, 322.82 +/- 218.31 pmol/L, respectively, P &lt; 0.05) On the other hand, serum FSH significantly decreased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of FSH value at 0, 4, 8, 12 weeks: 77.64 +/- 27.24, 40.33 +/- 21.64, 38.84 +/- 22.33, 30.90 +/- 24.32 IU/L, respectively, P &lt; 0.05) In conclusion, a daily dose of 2 g vaginal CEE cream raised the serum estradiol level close to the normal level in the follicular phase of the normal menstrual cycle. However, even though FSH significantly decreased it did not reach the premenopausal level.</description><subject>Administration, Topical</subject><subject>Adult</subject><subject>Estradiol - blood</subject><subject>Estrogens - administration &amp; dosage</subject><subject>Female</subject><subject>Follicle Stimulating Hormone - blood</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Osteoporosis, Postmenopausal - prevention &amp; control</subject><subject>Ovariectomy</subject><subject>Thailand</subject><subject>Treatment Outcome</subject><subject>Vagina</subject><issn>0125-2208</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1kE1LxDAYhHNQ3HX1L0hO3gpJmn7kKMv6AQte9FzeJG_XSD5q067or7fieppheJiBOSNrxkVVCMHaFbnM-Z0xWam6vCArztTia7kmsMvTCNYlTyFa2ifvnfFY5MmF2cPk4oG-pTGkiNTjEX2mLtKUhiVEM6XgvtHSzxQw0jn_0kc4uAie4lKcDhivyHkPPuP1STfk9X73sn0s9s8PT9u7fTFwIaYCpVa6b4XqjWAWjEAheSO0VrXiyGq0DLjkulSVbaApjTRKSmWWuNXMmHJDbv96hzF9zMt6F1w26D1ETHPumrYRnAm2gDcncNYBbTeMLsD41f2fUv4AOXhfjw</recordid><startdate>199710</startdate><enddate>199710</enddate><creator>Taechakraichana, N</creator><creator>Intraragsakul, A</creator><creator>Panyakhamlerd, K</creator><creator>Numchaisrika, P</creator><creator>Limpaphayom, K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199710</creationdate><title>Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen</title><author>Taechakraichana, N ; Intraragsakul, A ; Panyakhamlerd, K ; Numchaisrika, P ; Limpaphayom, K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-e4b9bf829fc20dac2e24172bb9691e06ed0a141b395d7a73c4c9449cd0a8b0cc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Administration, Topical</topic><topic>Adult</topic><topic>Estradiol - blood</topic><topic>Estrogens - administration &amp; dosage</topic><topic>Female</topic><topic>Follicle Stimulating Hormone - blood</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Osteoporosis, Postmenopausal - prevention &amp; control</topic><topic>Ovariectomy</topic><topic>Thailand</topic><topic>Treatment Outcome</topic><topic>Vagina</topic><toplevel>online_resources</toplevel><creatorcontrib>Taechakraichana, N</creatorcontrib><creatorcontrib>Intraragsakul, A</creatorcontrib><creatorcontrib>Panyakhamlerd, K</creatorcontrib><creatorcontrib>Numchaisrika, P</creatorcontrib><creatorcontrib>Limpaphayom, K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the Medical Association of Thailand</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Taechakraichana, N</au><au>Intraragsakul, A</au><au>Panyakhamlerd, K</au><au>Numchaisrika, P</au><au>Limpaphayom, K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen</atitle><jtitle>Journal of the Medical Association of Thailand</jtitle><addtitle>J Med Assoc Thai</addtitle><date>1997-10</date><risdate>1997</risdate><volume>80</volume><issue>10</issue><spage>626</spage><epage>630</epage><pages>626-630</pages><issn>0125-2208</issn><abstract>To assess the changing estradiol (E2) and follicle-stimulating hormone (FSH) level in oophorectomized women using vaginal estrogen. Serum estradiol and FSH were evaluated in 32 oophorectomized women using a daily dose of 2 g base of 1.25 mg vaginal conjugated equine estrogen (CEE) cream. The blood sample for hormone assay was collected 8-10 hours from the time of vaginal application. E2 and FSH levels were measured in the serum sample before and after commencing the study at 4, 8 and 12 weeks using the time-resolved fluoroimmunoassay method. Serum estradiol significantly increased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of E2 value at 0, 4, 8, 12 weeks: 9.97 +/- 12.13, 249.83 +/- 170.46, 299.38 +/- 190.65, 322.82 +/- 218.31 pmol/L, respectively, P &lt; 0.05) On the other hand, serum FSH significantly decreased from baseline value at 4, 8 and 12 weeks. (Mean +/- SD of FSH value at 0, 4, 8, 12 weeks: 77.64 +/- 27.24, 40.33 +/- 21.64, 38.84 +/- 22.33, 30.90 +/- 24.32 IU/L, respectively, P &lt; 0.05) In conclusion, a daily dose of 2 g vaginal CEE cream raised the serum estradiol level close to the normal level in the follicular phase of the normal menstrual cycle. However, even though FSH significantly decreased it did not reach the premenopausal level.</abstract><cop>Thailand</cop><pmid>10904564</pmid><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0125-2208
ispartof Journal of the Medical Association of Thailand, 1997-10, Vol.80 (10), p.626-630
issn 0125-2208
language eng
recordid cdi_proquest_miscellaneous_78721020
source MEDLINE; Alma/SFX Local Collection
subjects Administration, Topical
Adult
Estradiol - blood
Estrogens - administration & dosage
Female
Follicle Stimulating Hormone - blood
Humans
Middle Aged
Osteoporosis, Postmenopausal - prevention & control
Ovariectomy
Thailand
Treatment Outcome
Vagina
title Estradiol and follicle-stimulating hormone levels in oophorectomized women using vaginal estrogen
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T15%3A36%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Estradiol%20and%20follicle-stimulating%20hormone%20levels%20in%20oophorectomized%20women%20using%20vaginal%20estrogen&rft.jtitle=Journal%20of%20the%20Medical%20Association%20of%20Thailand&rft.au=Taechakraichana,%20N&rft.date=1997-10&rft.volume=80&rft.issue=10&rft.spage=626&rft.epage=630&rft.pages=626-630&rft.issn=0125-2208&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E78721020%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78721020&rft_id=info:pmid/10904564&rfr_iscdi=true